Identification
Instrument name
ADOCIA
Symbol
ADOC
ISIN code
FR0011184241
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description

<p>
Adocia specializes in the research and development of biotherapy products used in tissue regeneration and for treating chronic diseases.<br />
At the end of June 2011, the group had a portfolio of 4 products in clinical development (including two in phase 2; PDGF-BB, for treating diabetic foot ulcers, and HinsBet, quick-acting human insulin for treating diabetes).<span style="display: none">&nbsp;</span></p>

Website address
Operation
IPO date
IPO type

<p>
<font face="Arial" size="2"><font face="Arial" size="2">Initial Public Offering<span style="display: none">&nbsp;</span></font></font></p>

IPO type
Initial Public offering
Catégorie
IPO
Operation calendar

<p>
LISTING DATE: 14/02/2012<br />
TRADING DATE:&nbsp; 20/02/2012<span style="display: none">&nbsp;</span><span style="display: none">&nbsp;</span></p>

Price range
Indicative price range for the Offer: EUR 13.00 - EUR 15.88 ("The Offering Price")